Australian anti-cancer drug picked as one of the world’s top 10 most promising new drug products in 2011
18-Oct-2011 -
Immune System Therapeutics (IST) announced its lead anti-cancer product, MDX-1097, had been recognized as one of Windhover's Top 10 most promising new drug products for 2011. Windhover is a provider of business information to the pharmaceutical, biotechnology, and medical device industries. ...
cancer
Immune System Therapeutics
multiple myeloma
+1